MT Newswires8d agoneutral
Vertex Pharmaceuticals' Solid Q2, Raised Outlook Underscore Core Business Strength, RBC SaysVertex Pharmaceuticals (VRTX) reported a solid Q2 and raised its outlook, highlighting the strength
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
Vertex Pharmaceuticals (VRTX) reported a solid Q2 and raised its outlook, highlighting the strength
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.